Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 5 | 2018 | 935 | 0.810 |
Why?
|
| Isothiocyanates | 2 | 2012 | 18 | 0.670 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2018 | 5 | 0.640 |
Why?
|
| Annexin A2 | 1 | 2018 | 6 | 0.640 |
Why?
|
| Chaperonin 60 | 1 | 2018 | 18 | 0.630 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 107 | 0.590 |
Why?
|
| Vitis | 2 | 2015 | 31 | 0.420 |
Why?
|
| Cell-Matrix Junctions | 1 | 2012 | 2 | 0.420 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2012 | 29 | 0.410 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 1 | 2012 | 14 | 0.410 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2012 | 30 | 0.410 |
Why?
|
| Stilbenes | 2 | 2008 | 44 | 0.370 |
Why?
|
| Selenoproteins | 1 | 2012 | 159 | 0.350 |
Why?
|
| Plant Extracts | 2 | 2015 | 286 | 0.340 |
Why?
|
| Dietary Fiber | 1 | 2006 | 47 | 0.280 |
Why?
|
| Diet Records | 1 | 2006 | 60 | 0.280 |
Why?
|
| Nutrition Assessment | 1 | 2006 | 79 | 0.270 |
Why?
|
| Chemoprevention | 1 | 2005 | 35 | 0.250 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 99 | 0.250 |
Why?
|
| Carcinogens | 1 | 2005 | 124 | 0.240 |
Why?
|
| Glutathione | 1 | 2005 | 179 | 0.240 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 893 | 0.220 |
Why?
|
| Disease Progression | 2 | 2018 | 601 | 0.220 |
Why?
|
| Cell Proliferation | 2 | 2008 | 1198 | 0.220 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2015 | 110 | 0.180 |
Why?
|
| Anticarcinogenic Agents | 2 | 2012 | 65 | 0.180 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 1371 | 0.170 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 275 | 0.150 |
Why?
|
| Mice | 4 | 2012 | 5913 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1130 | 0.120 |
Why?
|
| Neoplasms | 1 | 2005 | 1103 | 0.120 |
Why?
|
| Male | 6 | 2018 | 20025 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 128 | 0.120 |
Why?
|
| Animals | 5 | 2012 | 15081 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 661 | 0.110 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2012 | 5 | 0.110 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 41 | 0.100 |
Why?
|
| Selenocysteine | 1 | 2012 | 55 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 59 | 0.100 |
Why?
|
| Humans | 7 | 2018 | 37093 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2012 | 337 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 259 | 0.090 |
Why?
|
| Genotype | 1 | 2012 | 730 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2012 | 933 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 89 | 0.080 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 21 | 0.080 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 20 | 0.080 |
Why?
|
| Seeds | 1 | 2007 | 35 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1609 | 0.070 |
Why?
|
| Nutritional Sciences | 1 | 2006 | 22 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 187 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 502 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 173 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2006 | 215 | 0.070 |
Why?
|
| Colonic Polyps | 1 | 2006 | 67 | 0.070 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2005 | 11 | 0.060 |
Why?
|
| Glutathione Reductase | 1 | 2005 | 23 | 0.060 |
Why?
|
| Educational Status | 1 | 2006 | 313 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 562 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 88 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 111 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2005 | 161 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2005 | 70 | 0.060 |
Why?
|
| Apoptosis | 2 | 2008 | 1398 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 935 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2005 | 186 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2006 | 454 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 807 | 0.050 |
Why?
|
| Cell Survival | 1 | 2005 | 864 | 0.050 |
Why?
|
| Cell Line | 1 | 2005 | 1354 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 2379 | 0.050 |
Why?
|
| Aged | 2 | 2015 | 6741 | 0.050 |
Why?
|
| Female | 2 | 2012 | 20969 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2007 | 1908 | 0.040 |
Why?
|
| Middle Aged | 2 | 2015 | 10129 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 803 | 0.040 |
Why?
|
| Rats | 1 | 2005 | 3483 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 42 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 974 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1039 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 1492 | 0.020 |
Why?
|
| Adult | 1 | 2006 | 11712 | 0.020 |
Why?
|
| Metribolone | 1 | 2008 | 3 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2008 | 26 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 90 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 122 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 306 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 623 | 0.020 |
Why?
|
| Estradiol | 1 | 2008 | 262 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 626 | 0.020 |
Why?
|